Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Chevron
CVX
|
+$317M |
| 2 |
Walmart Inc
WMT
|
+$218M |
| 3 |
Linde
LIN
|
+$174M |
| 4 |
PayPal
PYPL
|
+$133M |
| 5 |
Union Pacific
UNP
|
+$126M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$724M |
| 2 |
Uber
UBER
|
+$527M |
| 3 |
ExxonMobil
XOM
|
+$450M |
| 4 |
NVO
Novo Nordisk
NVO
|
+$365M |
| 5 |
Apple
AAPL
|
+$336M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.8% |
| 2 | Healthcare | 17.12% |
| 3 | Consumer Discretionary | 13.21% |
| 4 | Financials | 8.81% |
| 5 | Consumer Staples | 7.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2951
Mineralys Therapeutics
MLYS
$2.25B
| $409K | ﹤0.01% |
31,700
+6,200
| +24% | +$76.6K |
|
2952
Schwab Fundamental International Small Company Index ETF
FNDC
$3.05B
| $408K | ﹤0.01% |
+11,500
| New | +$395K |
|
2953
Pyxis Tankers
PXS
$48.7M
| $408K | ﹤0.01% |
85,601
+21,284
| +33% | +$95.9K |
|
2954
Anavex Life Sciences
AVXL
$255M
| $407K | ﹤0.01% |
+79,900
| New | +$450K |
|
2955
Five Star Bancorp
FSBC
$1.14B
| $407K | ﹤0.01% |
18,100
+736
| +4% | +$17.6K |
|
2956
Radiant Logistics
RLGT
$386M
| $406K | ﹤0.01% |
74,970
-21,430
| -22% | -$127K |
|
|
LABP
2957
DELISTED
Landos Biopharma, Inc. Common Stock
LABP
| $406K | ﹤0.01% |
18,890
+7,630
| +68% | +$50.6K |
|
2958
Ark Restaurants
ARKR
| $403K | ﹤0.01% |
29,311
-900
| -3% | -$12.8K |
|
2959
Trevi Therapeutics
TRVI
$2.59B
| $403K | ﹤0.01% |
116,842
-425,858
| -78% | -$950K |
|
|
SSKN
2960
DELISTED
Strata Skin Sciences
SSKN
| $402K | ﹤0.01% |
106,285
-460
| -0.4% | -$2.4K |
|
2961
JPMorgan International Research Enhanced Equity ETF
JIRE
$11.2B
| $401K | ﹤0.01% |
+6,400
| New | +$383K |
|
2962
USCB Financial Holdings
USCB
$406M
| $401K | ﹤0.01% |
35,211
-289
| -0.8% | -$3.34K |
|
|
DHC
2963
Diversified Healthcare Trust
DHC
$2.15B
| $398K | ﹤0.01% |
161,800
+118,164
| +271% | +$338K |
|
|
AIOS
2964
AIOS Tech
AIOS
$38.4M
| $398K | ﹤0.01% |
3,773
-1,910
| -34% | -$172K |
|
2965
Corbus Pharmaceuticals
CRBP
$166M
| $397K | ﹤0.01% |
+10,123
| New | +$250K |
|
2966
Union Bankshares
UNB
$106M
| $397K | ﹤0.01% |
13,032
+500
| +4% | +$15.2K |
|
2967
Highway Holdings
HIHO
$4.07M
| $396K | ﹤0.01% |
188,415
-2,000
| -1% | -$4.09K |
|
2968
First Trust Dorsey Wright Focus 5 ETF
FV
$3.61B
| $395K | ﹤0.01% |
+6,900
| New | +$372K |
|
2969
Cellectar Biosciences
CLRB
$20.5M
| $392K | ﹤0.01% |
+3,283
| New | +$356K |
|
|
KYNB
2970
Kyntra Bio
KYNB
$27.2M
| $391K | ﹤0.01% |
6,660
-20,676
| -76% | -$891K |
|
2971
Emerson Radio
MSN
$7.79M
| $391K | ﹤0.01% |
737,388
-5,800
| -0.8% | -$3.12K |
|
2972
Apogee Enterprises
APOG
$826M
| $390K | ﹤0.01% |
6,583
-7,500
| -53% | -$414K |
|
|
EDN
2973
Edenor
EDN
$1.17B
| $390K | ﹤0.01% |
22,024
+8,124
| +58% | +$147K |
|
2974
Acushnet Holdings
GOLF
$5.93B
| $389K | ﹤0.01% |
5,900
+1,500
| +34% | +$97.1K |
|
2975
Vanguard Real Estate ETF
VNQ
$39.2B
| $389K | ﹤0.01% |
+4,500
| New | +$384K |
|
Similar funds
Renaissance Technologies's Q1 2024 Portfolio in Review
As of Q1 2024, Renaissance Technologies held 4,246 positions worth $63.6B, down 1.5% from $64.6B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Renaissance Technologies withdrew a net $5.25B in Q1 2024, closing 582 positions and reducing 1,517 holdings. Its most notable exit was ExxonMobil, an estimated $450M position sold in full.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Renaissance Technologies opened a new position in Chevron worth $331M.
- Renaissance Technologies's largest Q1 2024 buy was Chevron: 2,097,623 shares worth $331M.
- Renaissance Technologies added most to Walmart Inc in Q1 2024, an estimated $218M increase.
- Renaissance Technologies's biggest Q1 2024 reduction was NVIDIA, cutting an estimated $724M.
- Renaissance Technologies fully exited ExxonMobil in Q1 2024, selling an estimated $450M.
- Renaissance Technologies's ten largest holdings make up 12% of its $63.6B portfolio in Q1 2024.
- Renaissance Technologies opened 563 new positions and closed 582 in Q1 2024.
- Renaissance Technologies's portfolio value fell 1.5% quarter-over-quarter to $63.6B.
Based on Renaissance Technologies's 13F filing for Q1 2024, filed 13 May 2024.